These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25924888)

  • 1. Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat.
    Chadha GS; Morris ME
    AAPS J; 2015 Jul; 17(4):965-75. PubMed ID: 25924888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Extended Minimal Physiologically Based Pharmacokinetic Model: Evaluation of Type II Diabetes Mellitus and Diabetic Nephropathy on Human IgG Pharmacokinetics in Rats.
    Chadha GS; Morris ME
    AAPS J; 2015 Nov; 17(6):1464-74. PubMed ID: 26276217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats.
    Kubota M; Watanabe R; Yamaguchi M; Hosojima M; Saito A; Fujii M; Fujimura S; Kadowaki M
    Br J Nutr; 2016 Oct; 116(8):1326-1335. PubMed ID: 27724997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased aldosterone levels in a model of type 2 diabetes mellitus.
    Fredersdorf S; Endemann DH; Luchner A; Heitzmann D; Ulucan C; Birner C; Schmid P; Stoelcker B; Resch M; Muders F; Riegger GA; Weil J
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):15-20. PubMed ID: 18726873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriateness of the Zucker Diabetic Fatty rat as a model for diabetic microvascular late complications.
    Hempe J; Elvert R; Schmidts HL; Kramer W; Herling AW
    Lab Anim; 2012 Jan; 46(1):32-9. PubMed ID: 22087029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Running Exercise Alleviates Early Progression of Nephropathy with Upregulation of Nitric Oxide Synthases and Suppression of Glycation in Zucker Diabetic Rats.
    Ito D; Cao P; Kakihana T; Sato E; Suda C; Muroya Y; Ogawa Y; Hu G; Ishii T; Ito O; Kohzuki M; Kiyomoto H
    PLoS One; 2015; 10(9):e0138037. PubMed ID: 26379244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
    Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
    Castoldi G; di Gioia CR; Bombardi C; Maestroni S; Carletti R; Steckelings UM; Dahlöf B; Unger T; Zerbini G; Stella A
    Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1123-31. PubMed ID: 25186297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
    Tawfik MK
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):600-9. PubMed ID: 22774400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.
    Chen TY; Ferruzzi MG; Wu QL; Simon JE; Talcott ST; Wang J; Ho L; Todd G; Cooper B; Pasinetti GM; Janle EM
    Mol Nutr Food Res; 2017 Oct; 61(10):. PubMed ID: 28568316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus.
    Pereira M; Gohin S; Lund N; Hvid A; Smitham PJ; Oddy MJ; Reichert I; Farlay D; Roux JP; Cleasby ME; Chenu C
    Osteoporos Int; 2017 Jan; 28(1):309-320. PubMed ID: 27468901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone downregulates Twist-1 expression in the kidney and protects renal function of Zucker diabetic fatty rats.
    Wang Z; Liu Q; Dai W; Hua B; Li H; Li W
    Biomed Pharmacother; 2019 Oct; 118():109346. PubMed ID: 31506251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
    Ohga S; Shikata K; Yozai K; Okada S; Ogawa D; Usui H; Wada J; Shikata Y; Makino H
    Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1141-50. PubMed ID: 17190910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats.
    Togashi Y; Miyamoto Y
    Exp Toxicol Pathol; 2013 Jul; 65(5):615-22. PubMed ID: 22795897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.
    Griggs RB; Donahue RR; Adkins BG; Anderson KL; Thibault O; Taylor BK
    J Pain; 2016 Mar; 17(3):359-73. PubMed ID: 26687453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
    Pelzer T; Jazbutyte V; Arias-Loza PA; Segerer S; Lichtenwald M; Law MP; Schäfers M; Ertl G; Neyses L
    Biochem Biophys Res Commun; 2005 Apr; 329(2):726-32. PubMed ID: 15737646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.